Engineering receptor-based decoys for the treatment of cancer using a yeast surface display platform
<p>Decoy receptors form a distinct class of targeted therapeutics that offer unique advantages compared to traditional antibody therapy. Since they are derived from preexisting signaling processes, they possess inherent ligand specificity and immune tolerance, which can significantly reduce of...
Main Author: | Wang, Y |
---|---|
Other Authors: | Giaccia, A |
Format: | Thesis |
Language: | English |
Published: |
2023
|
Similar Items
-
Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles
by: Gupta, D, et al.
Published: (2021) -
Construction of HGF-Displaying Yeast by Cell Surface Engineering
by: Seiji Shibasaki, et al.
Published: (2022-07-01) -
TNF Decoy Receptors Encoded by Poxviruses
by: Francisco Javier Alvarez-de Miranda, et al.
Published: (2021-08-01) -
Neutralization of BAFF and APRIL with engineered soluble BCMA decoy receptor for the treatment of B-cell malignancies
by: Zhang, XE
Published: (2023) -
An engineered interleukin‐11 decoy cytokine inhibits receptor signaling and proliferation in lung adenocarcinoma
by: Brianna J. McIntosh, et al.
Published: (2023-11-01)